Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oslo Hypertension Study.

P Leren, A Helgeland

    Drugs
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    The Oslo Hypertension Study found that treating mild hypertension with drugs, primarily diuretics and beta-blockers, did not reduce overall cardiovascular complications or mortality. Notably, drug treatment increased 10-year coronary heart disease mortality.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Simulating CSF flow dynamics in the normal and the Chiari I subarachnoid space during rest and exertion.

    AJNR. American journal of neuroradiology·2012
    Same author

    Effect of tonsillar herniation on cyclic CSF flow studied with computational flow analysis.

    AJNR. American journal of neuroradiology·2011
    Same author

    Cancer among men on cholesterol-lowering diets: Experience from five clinical trials.

    Lancet (London, England)·2010
    Same author

    Lung cancer and air pollution: a 27 year follow up of 16 209 Norwegian men.

    Thorax·2003
    Same author

    Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study.

    Journal of epidemiology and community health·1996
    Same author

    Risk of fatal stroke according to blood pressure level: an 18-year follow-up of the Oslo Study.

    Journal of hypertension·1995
    Same journal

    The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

    Drugs·2026
    Same journal

    Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

    Drugs·2026
    Same journal

    Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

    Drugs·2026
    Same journal

    Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

    Drugs·2026
    Same journal

    Relacorilant: First Approval.

    Drugs·2026
    Same journal

    Developmental Progress and Future Potential for Inhaled Biologics in the Treatment of Respiratory Diseases.

    Drugs·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology
    • Public Health

    Background:

    • Mild hypertension affects middle-aged men.
    • Long-term effects of hypertension treatment require investigation.

    Purpose of the Study:

    • To evaluate the long-term effects of drug treatment for mild hypertension.
    • To assess cardiovascular complications and mortality in treated versus untreated hypertensive men.

    Main Methods:

    • Randomized controlled trial involving 785 healthy men aged 40-49 with mild hypertension.
    • Drug-treated group received various antihypertensives (95% hydrochlorothiazide).
    • Control group received no drug treatment.

    Main Results:

    • No significant difference in total cardiovascular complications or total mortality between groups at 5 and 10 years.

    Related Experiment Videos

  • Pressure complications (stroke, aneurysms) occurred only in the control group.
  • Coronary events were more frequent in the drug-treated group, leading to significantly higher 10-year coronary heart disease mortality (14 vs 3).

    • Conclusions:

    • Drug treatment for mild hypertension, particularly with diuretics and beta-blockers, may not improve coronary heart disease outcomes and could potentially worsen them.
    • Adverse effects on lipid and carbohydrate metabolism by certain antihypertensives warrant consideration.
    • Alpha-adrenergic blockers like prazosin show potential for improving lipid profiles.